Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
113Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $17.40B | $1.09B | $1.60 |
| 2024 | $16.91B | $907.00M | $1.31 |
| 2023 | $17.23B | $735.00M | $1.04 |
| 2022 | $17.45B | $1.15B | $1.59 |
| 2021 | $15.65B | $1.76B | $2.39 |
Social Signal Score
Earnings
Tue, Nov 3(in 3 months)
Consensus estimate $-0.42 per share
Typical surprise +16.4% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Jul 30$2.30 vs $2.24beat
- Tue, May 5$1.50 vs $1.17beat
- Tue, Feb 3$0.22 vs $0.22miss
- Tue, Nov 4$-0.23 vs $-0.51beat
- Wed, Aug 6$2.20 vs $1.89beat
- Wed, May 7$1.13 vs $0.87beat
Estimates and results for CTVA via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
Project earnings forward and see what return today's price implies.
Seeded from CTVA's reported EPS growth of -9.5% a year over 4 years.
- EPS in 5 years
- $0.98
- Implied price
- $41.02
- Return from $76.68
- -11.8% a year
To earn 15.0% a year on these assumptions you'd need to buy at $20.39 — -73.4% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 30 | 36 | 42 | 48 | 54 |
|---|---|---|---|---|---|
| -19.5% | -26.6% | -23.9% | -21.5% | -19.4% | -17.5% |
| -14.5% | -22.1% | -19.2% | -16.6% | -14.4% | -12.3% |
| -9.5% | -17.5% | -14.4% | -11.8% | -9.4% | -7.2% |
| -4.5% | -12.9% | -9.7% | -6.9% | -4.4% | -2.1% |
| 0.5% | -8.4% | -5.0% | -2.0% | 0.6% | 3.0% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Mentions (2)
- Newszacks.com·3d ago·Neutral
Corteva's Higher 2026 Guidance Puts Investor Focus on Growth Drivers CTVA's Q2 earnings beat and raised 2026 outlook signal progress, but Crop Protection pricing and separation risks remain.
View source ↗ - Newszacks.com·3d ago·Positive
Corteva Growth Improves, But Valuation Limits Upside CTVA's stronger earnings outlook is supported by Seed growth and productivity gains, but Crop Protection pricing and separation risks persist.
View source ↗